Patent · US Expired

Hybrid interferons

US5071761A · kind A · utility

22Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 18, 1989
Grant dateDec 10, 1991
Priority date
Expiry dateJul 18, 2009

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/142
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel hybrid interferons are produced which are derived from lymphoblastoid interferons .alpha.-2 and .alpha.-3 belonging to the interferon .alpha.B and .alpha.D groups, respectively. The novel hybrid interferons possess valuable antiviral and antiproliferative properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.